المؤلفون: Zimerman A; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Lopes RD; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Stebbins AL; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Guimarães PO; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Haque G; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Melloni C; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Trollinger K; Duke Clinical Research Institute, Duke Medicine, Durham, NC., James SK; Uppsala Clinical Research Center, UCR, Uppsala University, Uppsala, Sweden., Alexander JH; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Tricoci P; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Roe MT; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Ohman EM; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Mahaffey KW; Department of Medicine, Stanford University, Stanford, CA., Held C; Uppsala Clinical Research Center, UCR, Uppsala University, Uppsala, Sweden., Tinga B; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Pieper KS; Duke Clinical Research Institute, Duke Medicine, Durham, NC., Alexander KP; Duke Clinical Research Institute, Duke Medicine, Durham, NC. Electronic address: karen.alexander@duke.edu.

المصدر: American heart journal [Am Heart J] 2016 Apr; Vol. 174, pp. 60-7. Date of Electronic Publication: 2016 Jan 12.

نوع المنشور: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Mosby Country of Publication: United States NLM ID: 0370465 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-6744 (Electronic) Linking ISSN: 00028703 NLM ISO Abbreviation: Am Heart J Subsets: MEDLINE

مواضيع طبية MeSH: Acute Coronary Syndrome/*complications , Anticoagulants/*therapeutic use , Myocardial Infarction/*etiology , Myocardial Revascularization/*methods , Platelet Aggregation Inhibitors/*therapeutic use , Risk Assessment/*methods, Acute Coronary Syndrome/mortality ; Acute Coronary Syndrome/therapy ; Aged ; Canada/epidemiology ; Double-Blind Method ; Electrocardiography ; Europe/epidemiology ; Female ; Follow-Up Studies ; Humans ; Incidence ; Male ; Middle Aged ; Myocardial Infarction/epidemiology ; Myocardial Infarction/prevention & control ; Patient Discharge ; Prognosis ; Retrospective Studies ; Survival Rate/trends ; United States/epidemiology

المؤلفون: Kenneth W. Mahaffey, John H. Alexander, Karen P. Alexander, Matthew T. Roe, Kathleen M. Trollinger, Patrícia O. Guimarães, Claes Held, Chiara Melloni, Ghazala Haque, Stefan James, Erik Magnus Ohman, André Zimerman, Pierluigi Tricoci, Renato D. Lopes, Brian Tinga, Karen S. Pieper, Amanda Stebbins

المصدر: American Heart Journal. 174:60-67

مصطلحات موضوعية: Male, Canada, medicine.medical_specialty, Acute coronary syndrome, Myocardial Infarction, 030204 cardiovascular system & hematology, Risk Assessment, law.invention, Electrocardiography, 03 medical and health sciences, 0302 clinical medicine, Double-Blind Method, Randomized controlled trial, law, Internal medicine, Myocardial Revascularization, medicine, Humans, 030212 general & internal medicine, Acute Coronary Syndrome, Intensive care medicine, Adverse effect, Aged, Retrospective Studies, business.industry, Proportional hazards model, Incidence, Incidence (epidemiology), Hazard ratio, Anticoagulants, Middle Aged, Prognosis, medicine.disease, Patient Discharge, United States, Europe, Survival Rate, Clinical trial, Platelet aggregation inhibitor, Female, Cardiology and Cardiovascular Medicine, business, Platelet Aggregation Inhibitors, Follow-Up Studies

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e7419fc6175849470fbcbec02e915a79
https://doi.org/10.1016/j.ahj.2016.01.003